RESUMEN
Letermovir is a human cytomegalovirus terminase inhibitor for cytomegalovirus infection prophylaxis in hematopoietic stem cell transplant recipients. Posaconazole (POS), a substrate of glucuronosyltransferase and P-glycoprotein, and voriconazole (VRC), a substrate of CYP2C9/19, are commonly administered to transplant recipients. Because coadministration of these azoles with letermovir is expected, the effect of letermovir on exposure to these antifungals was investigated. Two trials were conducted in healthy female subjects 18 to 55 years of age. In trial 1, single-dose POS 300 mg was administered alone, followed by a 7-day washout; then letermovir 480 mg once daily was given for 14 days with POS 300 mg coadministered on day 14. In trial 2, on day 1 VRC 400 mg was given every 12 hours; on days 2 and 3, VRC 200 mg was given every 12 hours, and on day 4 VRC 200 mg. On days 5 to 8, letermovir 480 mg was given once daily. Days 9 to 12 repeated days 1 to 4 coadministered with letermovir 480 mg once daily. In both trials, blood samples were collected for the assessment of the pharmacokinetic profiles of the antifungals, and safety was assessed. The geometric mean ratios (90%CIs) for POS+letermovir/POS area under the curve and peak concentration were 0.98 (0.83, 1.17) and 1.11 (0.95, 1.29), respectively. Voriconazole+letermovir/VRC area under the curve and peak concentration geometric mean ratios were 0.56 (0.51, 0.62) and 0.61 (0.53, 0.71), respectively. All treatments were generally well tolerated. Letermovir did not affect POS pharmacokinetics to a clinically meaningful extent but decreased VRC exposure. These results suggest that letermovir may be a perpetrator of CYP2C9/19-mediated drug-drug interactions.
Asunto(s)
Acetatos/farmacocinética , Antifúngicos/farmacocinética , Antivirales/farmacocinética , Quinazolinas/farmacocinética , Triazoles/farmacocinética , Voriconazol/farmacocinética , Acetatos/administración & dosificación , Acetatos/sangre , Administración Oral , Adulto , Antifúngicos/administración & dosificación , Antivirales/administración & dosificación , Área Bajo la Curva , Combinación de Medicamentos , Interacciones Farmacológicas , Femenino , Voluntarios Sanos , Humanos , Persona de Mediana Edad , Quinazolinas/administración & dosificación , Quinazolinas/sangre , Triazoles/administración & dosificación , Triazoles/sangre , Voriconazol/administración & dosificación , Voriconazol/sangreRESUMEN
Hereditary factors are thought to be responsible for impaired tendon function and joint laxity. The present study investigated the genotypic variability of knee laxity and stiffness and tendon mechanical and geometric properties among 16-week-old female A/J, C57BL/6J (B6), and C3H/HeJ (C3H) inbred mice. In one group of mice, knee mechanics were quantified using a custom loading apparatus enabling translation of the tibia against a stationary femur. In a second group, flexor digitorum longus and Achilles tendons from the left hind limb underwent biomechanical testing, while those of the contralateral limb were analyzed histologically for determination of cross-sectional area. Our results demonstrate that tendon and joint mechanics varied significantly among the inbred mouse strains, indicating that biomechanical properties are genetically determined. A/J mouse knees exhibited greater laxity (p < 0.001) and lower stiffness (p < 0.001) compared to those of the B6 and C3H mice. The genotypic differences in whole joint properties were similar to those of the tendons' structural biomechanical traits. Although body mass did not differ (p > 0.2) among the three strains, significant genotypic differences were found at the whole tendon, material quality, and morphological levels of the tissue hierarchy. Furthermore, genetic regulation of tendon mechanical properties varied with anatomic site. Patterns of genotypic differences in tendon size were not consistent with those of biomechanical properties, suggesting that unique combinations of structural and compositional factors contribute to tendon growth, adaptation, and development. Therefore, the three inbred strains constitute a useful experimental model to elucidate genetic control of structure-function relationships in normal and healing tendons and ligaments.
Asunto(s)
Tendón Calcáneo/fisiología , Variación Genética , Inestabilidad de la Articulación/genética , Rodilla de Cuadrúpedos/fisiología , Tendones/fisiología , Animales , Fenómenos Biomecánicos , Femenino , Genotipo , Inestabilidad de la Articulación/fisiopatología , Ratones , Ratones Endogámicos/genética , Modelos Animales , Modelos Genéticos , FenotipoRESUMEN
PURPOSE: The risk of gastrointestinal (GI) toxicity associated with the use of a traditional nonsteroidal antiinflammatory drug (NSAID) versus a cyclooxygenase-2 (COX-2) inhibitor was compared among patients in a managed care organization. METHODS: Patients over 18 years old who received a prescription for ibuprofen, naproxen, celecoxib, or rofecoxib between March 2001 and June 2001 were included in this study. All subjects were followed for 12 months for GI complications, medication use, and changes in physical conditions from baseline. A simplified risk-scoring scale was used to measure patients' risk of GI complications. RESULTS: A total of 172 patients were randomly selected: 86 receiving traditional NSAIDs and 86 receiving COX-2 inhibitors. Patients receiving COX-2 inhibitors were older and more likely to be receiving treatment for osteoarthritis (OA) or rheumatoid arthritis (RA), while patients taking traditional NSAIDs were more likely to be receiving treatment for acute pain. The average risk scores for patients receiving traditional NSAIDs and COX-2 inhibitors were 0.23% and 0.36%, respectively (p = 0.11). When stratified by indication, there was a significant difference in the risk score for acute pain (p = 0.02) but not for OA, RA, or chronic pain. No GI adverse effects occurred in either group. CONCLUSION: Among patients in a managed care organization who were taking NSAIDs, most were at low risk for an NSAID-related GI adverse effect. The risk of GI adverse effects did not differ significantly between patients treated with a traditional NSAID and those treated with a COX-2 inhibitor.
Asunto(s)
Atención Ambulatoria , Antiinflamatorios no Esteroideos/efectos adversos , Inhibidores de la Ciclooxigenasa/efectos adversos , Hemorragia Gastrointestinal/inducido químicamente , Adulto , Femenino , Humanos , Modelos Logísticos , Masculino , Programas Controlados de Atención en Salud , Persona de Mediana Edad , Estudios Retrospectivos , Factores de RiesgoRESUMEN
4-Substituted piperidine-derived trisubstituted ureas are reported as highly potent and selective inhibitors for sEH. The SAR outlines approaches to improve activity against sEH and reduce ion channel and CYP liability. With minimal off-target activity and a good PK profile, the benchmark 2d exhibited remarkable in vitro and ex vivo target engagement. The eutomer entA-2d also elicited vasodilation effect in rat mesenteric artery.
Asunto(s)
Epóxido Hidrolasas/antagonistas & inhibidores , Piperidinas/síntesis química , Urea/análogos & derivados , Urea/síntesis química , Animales , Disponibilidad Biológica , Línea Celular , Cristalografía por Rayos X , Inhibidores Enzimáticos del Citocromo P-450 , Sistema Enzimático del Citocromo P-450/metabolismo , Eicosanoides/metabolismo , Compuestos Epoxi/metabolismo , Humanos , Técnicas In Vitro , Canales Iónicos/antagonistas & inhibidores , Canales Iónicos/metabolismo , Riñón/efectos de los fármacos , Riñón/metabolismo , Arterias Mesentéricas/efectos de los fármacos , Arterias Mesentéricas/fisiología , Modelos Moleculares , Conformación Molecular , Relajación Muscular , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/fisiología , Piperidinas/farmacocinética , Piperidinas/farmacología , Ratas , Ratas Endogámicas SHR , Solubilidad , Estereoisomerismo , Relación Estructura-Actividad , Urea/farmacocinética , Urea/farmacologíaRESUMEN
Leishmania donovani-infected interleukin-13-/- BALB/c mice showed impaired initial gamma interferon secretion and incomplete granuloma assembly at parasitized liver foci. Nonetheless, control of early parasite replication, resolution of liver infection, and responsiveness to antileishmanial chemotherapy were intact. By itself, interleukin-13 does not appear to materially influence acquired resistance in this intracellular infection.
Asunto(s)
Interleucina-13/deficiencia , Interleucina-13/genética , Leishmania donovani/inmunología , Leishmaniasis Visceral/inmunología , Animales , Citocinas/biosíntesis , Citocinas/genética , Inmunidad Innata/genética , Interleucina-13/fisiología , Leishmaniasis Visceral/genética , Leishmaniasis Visceral/patología , Parasitosis Hepáticas/genética , Parasitosis Hepáticas/parasitología , Parasitosis Hepáticas/patología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones NoqueadosRESUMEN
Interleukin-12 (IL-12) orchestrates acquired resistance in intracellular Leishmania donovani infection in the liver, inducing gamma interferon and, in turn, macrophage activation and parasite killing. Nevertheless, testing in IL-18(-/-) mice compared to wild-type mice and in IL-12p40(-/-) compared to IL-12p35(-/-) mice also suggested both early-acting (IL-18) and late-acting (IL-23) antileishmanial effects independent of IL-12.
Asunto(s)
Interleucina-12/deficiencia , Interleucina-18/deficiencia , Interleucinas/deficiencia , Leishmania donovani/inmunología , Leishmaniasis Visceral/genética , Leishmaniasis Visceral/inmunología , Animales , Femenino , Predisposición Genética a la Enfermedad , Inmunidad Innata/genética , Interferón gamma/biosíntesis , Interleucina-12/genética , Interleucina-18/genética , Interleucina-23 , Subunidad p19 de la Interleucina-23 , Interleucinas/genética , Leishmaniasis Visceral/metabolismo , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones NoqueadosRESUMEN
The microbial role in mobilization of trace elements from land-applied wastewater sludge is not well-defined. Our study examined the leachability of trace elements (Cd, Cr, Cu, Mo, Ni, P, Pb, S, and Zn) from dewatered sludge as affected by treatments designed to alter microbial activity. Different levels of microbial activity were achieved by incubating sludge columns at 4, 16, 28, and 37 degrees C and by the addition of AgNO3 biocide at each temperature. Columns (with inert glass bead support beds) were subjected to six consecutive incubation-leaching cycles, each consisting of 7.3-d incubation followed by 16-h leaching with synthetic acid rain. Glucose mineralization tests were used to assess overall microbial activity. Significant acidification and trace element leaching occurred when conditions favored microbial activity (16 and 28 degrees C). Extent of mobilization was element-specific with Zn, Ni, and Cu showing the greatest mobilization (99, 67, and 57%, respectively). Mobilization was reduced but still substantial at 4 degrees C. Conditions that best inhibited microbial activity (37 degrees C or biocide at any temperature) resulted in the least mobilization. Characterization of enrichments performed using thiosulfate as the sole energy source revealed the presence of both known and putative S-oxidizing bacteria in the sludge. The results suggest that microbial acidification via S oxidation can mobilize trace elements from sludge. Elemental mobility in field situations would also be governed by other factors, including the capacity of soil to buffer acidification and to adsorb mobilized elements.